Stelios Papadopolous, Ph.D., a pioneering leader in biotech, appointed to Board of Directors; two industry veterans joined management team as ...
Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors
This includes serving as an investment banker at Cowen & Co., LLC and PaineWebber, Incorporated and, prior to that, in equity research at Drexel Burnham Lambert and Donaldson, Lufkin and Jenrette.
So, let's take a look at Apollo's top ten holdings. Apollo was born in 1990, rising from the ashes of Drexel Burnham Lambert, the infamous junk bond house that imploded in scandal. However ...
Mr. Kirsch began his career at Drexel Burnham Lambert, Inc., an investment banking firm. Mr. Kirsch serves on the Board of Directors of Liquidia Technologies, Inc. (Nasdaq: LQDA). He previously ...
and Vice President in the Equity Research Department of Drexel Burnham Lambert, covering the biotechnology industry. Dr. Papadopolous will serve on the Audit and Compensation Committees of Ovid ...
Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the ...
Hosted on MSN23d
Untimely death of ‘the Jackie Robinson of Wall Street’ who created the first Black-owned billion-dollar companyHe teamed up with Michael Milken, the junk bond impresario and senior executive of the now-defunct investment bank of Drexel Burnham Lambert, to acquire Beatrice International Foods, his website says.
Later, he worked with Michael Milken at Drexel Burnham Lambert, a partnership that left a lasting impression. “Milken has been a significant inspiration,” Peizer says. “He demonstrated how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results